Spinal CBX2 contributes to neuropathic pain by activating ERK signaling pathway in male mice

Meiling Han1, Fan Zhang1, Ying Wang1

  • 1Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou 221004, China; Department of Anesthesiology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.

PubMed

Insights

Nerve injury causes neuropathic pain by upregulating chromobox 2 (CBX2) protein post-transcriptionally. Inhibiting CBX2 in the spinal cord may offer therapeutic benefits for pain relief.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pain Research

Background:

  • Neuropathic pain arises from deregulated spinal cord proteins after nerve injury.
  • Post-transcriptional regulation plays a crucial role in controlling protein levels.

Purpose of the Study:

  • To identify proteins regulated post-transcriptionally after nerve injury.
  • To investigate the role of chromobox 2 (CBX2) in neuropathic pain.

Main Methods:

  • Integrated transcriptome (RNA sequencing) and translatome (ribosome profiling sequencing) analyses.
  • Investigated CBX2 distribution and function in spinal cord neurons.
  • Utilized animal models of nerve injury and pain.

Main Results:

  • Identified chromobox 2 (CBX2) as upregulated post-transcriptionally in the spinal cord after nerve injury.
  • CBX2 upregulation promoted neuronal and astrocyte hyperactivity, leading to pain hypersensitivity.
  • CBX2 activates the ERK pathway and upregulates CXCL13, contributing to astrocyte activation and pain.

Conclusions:

  • Spinal cord CBX2 upregulation is a key driver of neuropathic pain.
  • CBX2 influences pain processing via the ERK pathway and CXCL13 signaling.
  • Targeting CBX2 may represent a novel therapeutic strategy for neuropathic pain.

Related Concept Videos